Intertransverse Process Block for Quality of Recovery Post-Open Hepatectomy

Launched by CHINESE UNIVERSITY OF HONG KONG · Apr 25, 2025

Keywords

ClinConnect Summary

This clinical trial is investigating a method called the Intertransverse Process Block (ITPB) to help improve recovery for patients undergoing major liver surgery, known as open hepatectomy. The main goal of the study is to see if this technique can reduce pain and enhance the overall quality of recovery in patients after their surgery. Researchers will measure how well patients feel 15 different aspects of their recovery, such as comfort and physical ability, at 24 and 48 hours after the procedure. They will also look at other factors like pain levels, the amount of pain medication needed, and how long it takes for patients to be ready to leave the hospital.

To participate in this trial, adults aged 18 to 75 years who are having open hepatectomy for liver issues may be eligible, provided they have a certain level of health (ASA I to III). However, those who refuse to take part, have infections, bleeding disorders, or are allergic to local anesthetics won't be able to join. While the study is not currently recruiting participants, it aims to gather important information on how the ITPB may help enhance recovery for individuals undergoing this type of surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - Adult patients aged 18-75 years of ASA I - III physical status classification undergoing open hepatectomy for benign or malignant liver lesion.
• Exclusion Criteria:
• • Patient refusal
• • Patients who are unable to comprehend the QoR15 form
• • Local or systemic infection
• • Coagulopathy leading to absolute contraindication to regional anesthesia
• • Contraindication to local anaesthetics (LA) such as LA allergy